24例卵巢交界性上皮性肿瘤的临床及病理分析  

Clinical and Pathologic Study in Ovarian Borderline Epithelial Tumor

作　　者：娄越亮[1] 马丽茜[2] 付玉兰 张燮良[1] 战忠利[4] 

机构地区：[1]天津市肿瘤医院,天津300060 [2]天津医科大学第二医院,天津300211 [3]陕西省肿瘤医院,西安710061 [4]天津市肿瘤研究所,天津300060

出　　处：《浙江肿瘤》1997年第3期148-149,共2页

摘　　要：目的：探讨卵巢上皮性交界性肿瘤的病理学改变、临床分期及手术范围对预后的影响、方法：分析1975年至1992年卵巢交界性上皮性肿瘤24例的临床资料、病理及随访结果。结果：24例中浆液性8例.粘液性15例，混合性1例。临床Ⅰ期14例、Ⅱ期5例、Ⅲ期5例。现22例存活（占92％），2例死了肿瘤并发症肠梗阻。结论：提示细致的病理分析是诊断交界性上皮性肿瘤的关键预后与手术方式及化疗关系不密切而与肿瘤分期及术后有无肿瘤残存有关;对肿瘤复发的病例多次手术治疗是必要的。Purpose: To investigate the relation of pathologic change, clinical staging and opcrative extent to prognosis in ovarian borderline epithehal tumor. Method: Clinical material, pathologic change and resull of followup were analysed in a series of 24 cases with ovarian borderline epithelial tumor from 1975 to 1992. Results: Among these patients, 8 were of serous, 15 muctnous, 1 mixtural. Fourteen cases were classified as of stage Ⅰ; 5 cases, stage Ⅱ and 5 cases, stage Ⅲ according to the FTGO staging. Twenty two cases were still alive and 2 cases of stage Ⅲ died tue to complications. Conclusion: A carelul pathologic analysis is the key to diagnosis in borderline cases. The prognosis is not related to clinlcal staging. It is necessary to perform operation repeatedly for recurrent case.

关 键 词：卵巢肿瘤 交生肿瘤 病理学 预后 

分 类 号：R737.310.2[医药卫生—肿瘤]